{"id":398537,"date":"2020-12-11T20:08:08","date_gmt":"2020-12-12T01:08:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=398537"},"modified":"2020-12-11T20:08:08","modified_gmt":"2020-12-12T01:08:08","slug":"annual-changes-to-the-nasdaq-biotechnology-index","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/","title":{"rendered":"Annual Changes to the Nasdaq Biotechnology Index"},"content":{"rendered":"
\n

NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 21, 2020.<\/p>\n

The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market\u00ae (Nasdaq\u00ae) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).<\/p>\n

The following 100 securities will be added to the Index:<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
EXCHANGE<\/td>\nSYMBOL<\/td>\nCOMPANY NAME<\/td>\n<\/tr>\n
Nasdaq<\/td>\nABUS<\/td>\nArbutus Biopharma Corporation<\/td>\n<\/tr>\n
Nasdaq<\/td>\nADAP<\/td>\nAdaptimmune Therapeutics plc<\/td>\n<\/tr>\n
Nasdaq<\/td>\nAKUS<\/td>\nAkouos, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nALT<\/td>\nAltimmune, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nALVR<\/td>\nAlloVir, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nALXO<\/td>\nALX Oncology Holdings Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nAMTI<\/td>\nApplied Molecular Transport Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nANNX<\/td>\nAnnexon, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nAPLT<\/td>\nApplied Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nAPRE<\/td>\nAprea Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nARCT<\/td>\nArcturus Therapeutics Holdings Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nARQT<\/td>\nArcutis Biotherapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nAVDL<\/td>\nAvadel Pharmaceuticals plc<\/td>\n<\/tr>\n
Nasdaq<\/td>\nAZN<\/td>\nAstraZeneca PLC<\/td>\n<\/tr>\n
Nasdaq<\/td>\nBDTX<\/td>\nBlack Diamond Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nBEAM<\/td>\nBeam Therapeutics Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nBNTX<\/td>\nBioNTech SE<\/td>\n<\/tr>\n
Nasdaq<\/td>\nCABA<\/td>\nCabaletta Bio, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nCALA<\/td>\nCalithera Biosciences, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nCDXS<\/td>\nCodexis, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nCLVS<\/td>\nClovis Oncology, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nCNCE<\/td>\nConcert Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nCNST<\/td>\nConstellation Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nCRNX<\/td>\nCrinetics Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nCRTX<\/td>\nCortexyme, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nFMTX<\/td>\nForma Therapeutics Holdings, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nFPRX<\/td>\nFive Prime Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nFREQ<\/td>\nFrequency Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nFULC<\/td>\nFulcrum Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nFUSN<\/td>\nFusion Pharmaceuticals Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nGBIO<\/td>\nGeneration Bio Co.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nGMDA<\/td>\nGamida Cell Ltd.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nHARP<\/td>\nHarpoon Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nIDYA<\/td>\nIDEAYA Biosciences, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nIGMS<\/td>\nIGM Biosciences, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nIMAB<\/td>\nI-MAB<\/td>\n<\/tr>\n
Nasdaq<\/td>\nIMUX<\/td>\nImmunic, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nIMVT<\/td>\nImmunovant, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nINZY<\/td>\nInozyme Pharma, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nISEE<\/td>\nIVERIC bio, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nITOS<\/td>\niTeos Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nJNCE<\/td>\nJounce Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nKALA<\/td>\nKala Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nKALV<\/td>\nKalVista Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nKDMN<\/td>\nKadmon Holdings, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nKDNY<\/td>\nChinook Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nKLDO<\/td>\nKaleido Biosciences, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nKMDA<\/td>\nKamada Ltd.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nKNSA<\/td>\nKiniksa Pharmaceuticals, Ltd.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nKROS<\/td>\nKeros Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nKRYS<\/td>\nKrystal Biotech, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nKZR<\/td>\nKezar Life Sciences, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nLEGN<\/td>\nLegend Biotech Corporation<\/td>\n<\/tr>\n
Nasdaq<\/td>\nLRMR<\/td>\nLarimar Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nMDGL<\/td>\nMadrigal Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nMNOV<\/td>\nMediciNova, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nMRNS<\/td>\nMarinus Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nMRSN<\/td>\nMersana Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nNK<\/td>\nNantKwest, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nNKTX<\/td>\nNkarta, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nNLTX<\/td>\nNeoleukin Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nNRIX<\/td>\nNurix Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nNVAX<\/td>\nNovavax, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nNXTC<\/td>\nNextCure, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nOCUL<\/td>\nOcular Therapeutix, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nODT<\/td>\nOdonate Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nORIC<\/td>\nOric Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nOVID<\/td>\nOvid Therapeutics Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nPAHC<\/td>\nPhibro Animal Health Corporation<\/td>\n<\/tr>\n
Nasdaq<\/td>\nPAND<\/td>\nPandion Therapeutics Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nPASG<\/td>\nPassage Bio, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nPCVX<\/td>\nVaxcyte, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nPLRX<\/td>\nPliant Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nPRTK<\/td>\nParatek Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nPRVB<\/td>\nProvention Bio, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nPSTX<\/td>\nPoseida Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nRAPT<\/td>\nRAPT Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nRDHL<\/td>\nRedhill Biopharma Ltd.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nREPL<\/td>\nReplimune Group, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nRLAY<\/td>\nRelay Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nRLMD<\/td>\nRelmada Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nRNA<\/td>\nAvidity Biosciences, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nRPRX<\/td>\nRoyalty Pharma plc<\/td>\n<\/tr>\n
Nasdaq<\/td>\nRPTX<\/td>\nRepare Therapeutics Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nRVMD<\/td>\nRevolution Medicines, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nSELB<\/td>\nSelecta Biosciences, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nSMMT<\/td>\nSummit Therapeutics Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nSNDX<\/td>\nSyndax Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nSPRO<\/td>\nSpero Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nSTRO<\/td>\nSutro Biopharma, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nSURF<\/td>\nSurface Oncology, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nSWTX<\/td>\nSpringWorks Therapeutics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nTCRR<\/td>\nTCR2 Therapeutics Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nVIE<\/td>\nViela Bio, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nVIR<\/td>\nVir Biotechnology, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nVSTM<\/td>\nVerastem, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nVYNE<\/td>\nVYNE Therapeutics Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nXENE<\/td>\nXenon Pharmaceuticals Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nZIOP<\/td>\nZIOPHARM Oncology Inc<\/td>\n<\/tr>\n
Nasdaq<\/td>\nZNTL<\/td>\nZentalis Pharmaceuticals, Inc.<\/td>\n<\/tr>\n<\/table>\n

As a result of the reconstitution, the following 16 securities will be removed from the Index:<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
EXCHANGE<\/td>\nSYMBOL<\/td>\nCOMPANY NAME<\/td>\n<\/tr>\n
Nasdaq<\/td>\nADMA<\/td>\nADMA Biologics Inc<\/td>\n<\/tr>\n
Nasdaq<\/td>\nAMRS<\/td>\nAmyris, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nAXNX<\/td>\nAxonics Modulation Technologies, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nCERS<\/td>\nCerus Corporation<\/td>\n<\/tr>\n
Nasdaq<\/td>\nCRBP<\/td>\nCorbus Pharmaceuticals Holdings, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nEOLS<\/td>\nEvolus, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nEYPT<\/td>\nEyePoint Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nGLYC<\/td>\nGlycoMimetics, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nGRTS<\/td>\nGritstone Oncology, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nLXRX<\/td>\nLexicon Pharmaceuticals, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nNVCR<\/td>\nNovoCure Limited<\/td>\n<\/tr>\n
Nasdaq<\/td>\nOPTN<\/td>\nOptiNose, Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nPRQR<\/td>\nProQR Therapeutics N.V.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nQTRX<\/td>\nQuanterix Corporation<\/td>\n<\/tr>\n
Nasdaq<\/td>\nSLDB<\/td>\nSolid Biosciences Inc.<\/td>\n<\/tr>\n
Nasdaq<\/td>\nTECH<\/td>\nBio-Techne Corp<\/td>\n<\/tr>\n<\/table>\n

\n About Nasdaq Global Indexes<\/strong>
\n
Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares\u00ae), Global Equity, Green Economy, Nordic and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide-spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index and design solutions to financial organizations worldwide.<\/p>\n

\n About Nasdaq <\/strong>
\n
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn<\/a>, on Twitter @Nasdaq<\/a>, or at www.nasdaq.com<\/a>.<\/p>\n

\n Media Relations Contact<\/strong>
\n
Emily Pan
(646) 637-3964
emily.pan@nasdaq.com<\/a><\/p>\n

\n Issuer & Investor Contact<\/strong>
\n
Index Client Services
indexservices@nasdaq.com<\/a><\/p>\n

\n The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq\u2019s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.<\/em>\n <\/p>\n

– NDAQG-<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 21, 2020. The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market\u00ae (Nasdaq\u00ae) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The following 100 securities will be added to the Index: EXCHANGE SYMBOL COMPANY NAME Nasdaq ABUS Arbutus Biopharma Corporation Nasdaq ADAP Adaptimmune Therapeutics plc Nasdaq AKUS Akouos, Inc. Nasdaq ALT Altimmune, Inc. Nasdaq ALVR AlloVir, Inc. Nasdaq ALXO ALX Oncology Holdings Inc. Nasdaq AMTI Applied Molecular … <\/p>\n

Continue reading “Annual Changes to the Nasdaq Biotechnology Index”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-398537","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAnnual Changes to the Nasdaq Biotechnology Index - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Annual Changes to the Nasdaq Biotechnology Index - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 21, 2020. The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market\u00ae (Nasdaq\u00ae) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The following 100 securities will be added to the Index: EXCHANGE SYMBOL COMPANY NAME Nasdaq ABUS Arbutus Biopharma Corporation Nasdaq ADAP Adaptimmune Therapeutics plc Nasdaq AKUS Akouos, Inc. Nasdaq ALT Altimmune, Inc. Nasdaq ALVR AlloVir, Inc. Nasdaq ALXO ALX Oncology Holdings Inc. Nasdaq AMTI Applied Molecular … Continue reading "Annual Changes to the Nasdaq Biotechnology Index"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-12T01:08:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMTE1MyMzODY4NDcwIzIwMTE0Nzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Annual Changes to the Nasdaq Biotechnology Index\",\"datePublished\":\"2020-12-12T01:08:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/\"},\"wordCount\":959,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMTE1MyMzODY4NDcwIzIwMTE0Nzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/\",\"name\":\"Annual Changes to the Nasdaq Biotechnology Index - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMTE1MyMzODY4NDcwIzIwMTE0Nzg=\",\"datePublished\":\"2020-12-12T01:08:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMTE1MyMzODY4NDcwIzIwMTE0Nzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMTE1MyMzODY4NDcwIzIwMTE0Nzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annual-changes-to-the-nasdaq-biotechnology-index\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Annual Changes to the Nasdaq Biotechnology Index\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Annual Changes to the Nasdaq Biotechnology Index - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/","og_locale":"en_US","og_type":"article","og_title":"Annual Changes to the Nasdaq Biotechnology Index - Market Newsdesk","og_description":"NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 21, 2020. The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market\u00ae (Nasdaq\u00ae) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The following 100 securities will be added to the Index: EXCHANGE SYMBOL COMPANY NAME Nasdaq ABUS Arbutus Biopharma Corporation Nasdaq ADAP Adaptimmune Therapeutics plc Nasdaq AKUS Akouos, Inc. Nasdaq ALT Altimmune, Inc. Nasdaq ALVR AlloVir, Inc. Nasdaq ALXO ALX Oncology Holdings Inc. Nasdaq AMTI Applied Molecular … Continue reading \"Annual Changes to the Nasdaq Biotechnology Index\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-12T01:08:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMTE1MyMzODY4NDcwIzIwMTE0Nzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Annual Changes to the Nasdaq Biotechnology Index","datePublished":"2020-12-12T01:08:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/"},"wordCount":959,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMTE1MyMzODY4NDcwIzIwMTE0Nzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/","name":"Annual Changes to the Nasdaq Biotechnology Index - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMTE1MyMzODY4NDcwIzIwMTE0Nzg=","datePublished":"2020-12-12T01:08:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMTE1MyMzODY4NDcwIzIwMTE0Nzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMTE1MyMzODY4NDcwIzIwMTE0Nzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annual-changes-to-the-nasdaq-biotechnology-index\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Annual Changes to the Nasdaq Biotechnology Index"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=398537"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398537\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=398537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=398537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=398537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}